Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma (MREO) Return on Equity (2023 - 2025)

Mereo BioPharma (MREO) has disclosed Return on Equity for 3 consecutive years, with 0.83% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Equity rose 1400.0% to 0.83% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.83%, a 1400.0% increase, with the full-year FY2024 number at 0.78%, down 20.0% from a year prior.
  • Return on Equity was 0.83% for Q3 2025 at Mereo BioPharma, up from 0.87% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 7.48% in Q4 2024 to a low of 14.82% in Q3 2024.
  • A 3-year average of 1.13% and a median of 0.56% in 2024 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: crashed -1443bps in 2024, then skyrocketed 1400bps in 2025.
  • Mereo BioPharma's Return on Equity stood at 0.56% in 2023, then surged by 1436bps to 7.48% in 2024, then tumbled by -111bps to 0.83% in 2025.
  • Per Business Quant, the three most recent readings for MREO's Return on Equity are 0.83% (Q3 2025), 0.87% (Q2 2025), and 0.78% (Q1 2025).